Bortezomib 2mg Injection Bortemap

Velcade (bortezomib) is a targeted therapy, which is a kind of Bortezomib 2mg Injection Bortemap. Velcade is a proteasome inhibitor, which is a type of medication. The FDA has given it the approval to treat multiple myeloma and mantle cell lymphoma.

The medication Bortezomib 2mg Injection Bortemap is used to treat multiple myeloma, (a type of cancer of the bone marrow. Bortezomib is likewise used to treat individuals with mantle cell lymphoma (a quickly developing disease that starts in the cells of the invulnerable framework). Bortezomib has a place in the class of drugs known as antineoplastic specialists.

• Dizziness,
• lightheadedness,
• nausea,
• vomiting,
• loss of appetite,
• diarrhea,
• constipation,
• fatigue,
• weakness or pain/redness may occur at the injection site.
• Normal antagonistic impacts incorporate sickness,
• retching, and the runs.
• Your doctor might prescribe a drug to forestall or ease sickness, regurgitate, or run in certain conditions.

Hair loss is a common occurrence. Balding is certainly not an immediate symptom of Velcade, yet it very well may be brought about by the different meds you’re taking with it. Individuals utilizing Velcade in addition to the cytotoxic drug cyclophosphamide, for instance, may experience going bald.

Because bortezomib is supplied parenterally, the new medicine provides the convenience of oral administration. Initially, it was only accessible as an intravenous infusion, but it is now also available as a subcutaneous formulation.

Check this Anti Cancer product Bortezomib 2mg Injection Bortenat or you may explore more Anti Cancer products by clicking here

We are an exporter from India and work in many countries, such as the UAE, Oman, Qatar, Myanmar, Saudi Arabia, the Netherlands, Albania, Saint Lucia, Jordan, Romania, and South Africa.